Answers are grounded in this paper and cite their sources.
Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease that is caused by the progressive occlusion of the distal pulmonary arteries, eventually leading to right heart failure and death. Almost 40% of patients with PAH are iron deficient. Although widely studied, the mechanisms linking between PAH and iron deficiency remain unclear. Here we review the mechanisms regulating iron homeostasis and the preclinical and clinical data available on iron deficiency in PAH. Then we discuss the potential implications of iron deficiency on the development and management of PAH.
No takes yet. Share an insight, caveat, or question.
Quatredeniers et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: